Skip to main content
Clinical Trials/JPRN-jRCTs032220261
JPRN-jRCTs032220261
Recruiting
未知

The Efficacy of Guided Bone Regeneration Using Cytrans Granule and Cytrans Elashield on Exposed Implant Sites; A clinical trial

Marukawa Eriko0 sites20 target enrollmentAugust 10, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Tooth Loss/Alveolar Bone Losses
Sponsor
Marukawa Eriko
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Marukawa Eriko

Eligibility Criteria

Inclusion Criteria

  • Patients aged 20 years old or more who can acquire written consent by themselves for participation in this study and who meet both of the following conditions will be selected.
  • 1\. Patients aged 20 years old or more and below 80\.
  • 2\. Patients who have been fully informed of the study and who have given written consent of their own free will after full understanding of the study.

Exclusion Criteria

  • The following patients are excluded from this study.
  • 1\. Patients with implants which was not able to achieve initial stability.
  • 2\. Patients with insufficient periapical bone volume, with an exposed implant area of more than 5 mm.
  • 3\. Patients with severe blood disorder or bone target hormone metabolic disorders.
  • 4\. Patients who suspected collagenosis and the abnormalities of calcium metabolism organs such as kidney and gastrointestinal tract
  • 5\.Patients under dialysis treatment or steroid use.
  • 6\. Uncontrolled diabetes mellitus patients who have had not adequate glycemic control (HbA1c less than 6\.9%).
  • 7\. Patients with uncontrollable complications that are restricted from observing the requirements of this clinical research, such as severe disease (infection, immunodeficiency, heart disease, etc) or psychiatric disorder.
  • 8\. Patients with or with a history of malignant tumors.
  • 9\. Patients under anti\-resorptive agents medication.

Outcomes

Primary Outcomes

Not specified

Similar Trials